Moreover, due to its potential to induce acute myeloid leukemia (AML) cell proliferation,14 concerns about the increased risk of relapse in myeloid leukemia, especially with early G‐CSF initiation following HCT, have been raised. The gene discussed is CSF3; the disease is acute myeloid leukemia.